These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of antileukotrienes in asthma management. Tan RA. Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901 [Abstract] [Full Text] [Related]
3. Benefit-risk assessment of antileukotrienes in the management of asthma. García-Marcos L, Schuster A, Pérez-Yarza EG. Drug Saf; 2003 Jan; 26(7):483-518. PubMed ID: 12735786 [Abstract] [Full Text] [Related]
5. Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal? Wechsler ME, Pauwels R, Drazen JM. Drug Saf; 1999 Oct; 21(4):241-51. PubMed ID: 10514017 [Abstract] [Full Text] [Related]
6. Antileukotrienes and asthma: alternative or adjunct to inhaled steroids? Kavuru MS, Subramony R, Vann AR. Cleve Clin J Med; 1998 Oct; 65(10):519-26. PubMed ID: 9830785 [Abstract] [Full Text] [Related]
7. New treatments for asthma: the role of leukotriene modifier agents. Valacer DJ. J Natl Med Assoc; 1999 Aug; 91(8 Suppl):26S-39S. PubMed ID: 12653390 [Abstract] [Full Text] [Related]
8. Antileukotriene drugs in the management of asthma. Wenzel SE. JAMA; 1999 Aug; 280(24):2068-9. PubMed ID: 9875862 [No Abstract] [Full Text] [Related]
9. [The role of leukotrienes in inflammation and leukotriene inhibitors]. Kupczyk M, Kuna P. Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480 [Abstract] [Full Text] [Related]
10. Use of leukotriene antagonists in childhood asthma. Krawiec ME, Wenzel SE. Curr Opin Pediatr; 1999 Dec; 11(6):540-7. PubMed ID: 10590913 [Abstract] [Full Text] [Related]
11. New perspectives for asthma treatment: anti-leukotriene drugs. García-Marcos L, Schuster A. Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608 [Abstract] [Full Text] [Related]
12. A risk-benefit assessment of antileukotrienes in asthma. Smith LJ. Drug Saf; 1998 Sep; 19(3):205-18. PubMed ID: 9747667 [Abstract] [Full Text] [Related]
13. Leukotriene modifiers in pediatric asthma management. Bisgaard H. Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473 [Abstract] [Full Text] [Related]
14. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma. Kubavat AH, Khippal N, Tak S, Rijhwani P, Bhargava S, Patel T, Shah N, Kshatriya RR, Mittal R. Am J Ther; 2013 Feb; 20(2):154-62. PubMed ID: 22926233 [Abstract] [Full Text] [Related]
15. Leukotriene modifiers: new drugs, old and new reactions. Rosenwasser LJ. J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):374-5. PubMed ID: 10069868 [No Abstract] [Full Text] [Related]
16. Leukotriene receptor antagonists and related compounds. Wenzel SE. Can Respir J; 1999 Mar; 6(2):189-93. PubMed ID: 10322101 [Abstract] [Full Text] [Related]
17. Safety of antileukotriene agents in asthma management. Spector SL, Antileukotriene Working Group. Ann Allergy Asthma Immunol; 2001 Jun; 86(6 Suppl 1):18-23. PubMed ID: 11426912 [Abstract] [Full Text] [Related]
18. Asthma therapy with agents preventing leukotriene synthesis or action. Drazen JM. Proc Assoc Am Physicians; 1999 Jun; 111(6):547-59. PubMed ID: 10591083 [Abstract] [Full Text] [Related]
19. Critical appraisal of antileukotriene use in asthma management. Polosa R. Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121 [Abstract] [Full Text] [Related]
20. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Wechsler ME, Finn D, Gunawardena D, Westlake R, Barker A, Haranath SP, Pauwels RA, Kips JC, Drazen JM. Chest; 2000 Mar; 117(3):708-13. PubMed ID: 10712995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]